Pacific Biosciences Of California (PACB) Finished Goods (2011 - 2026)

Pacific Biosciences Of California has reported Finished Goods for 16 years, with the latest figure at $12.5 million in Q2 2026.

• On a quarterly basis, Finished Goods fell 15.26% year-over-year to $12.5 million in Q2 2026; TTM through Jun 2026 was $12.5 million, a 15.26% decrease from a year earlier, with the FY2025 full-year figure at $10.3 million, down 26.81% from the prior year.
• Finished Goods was $12.5 million for Q2 2026 at Pacific Biosciences Of California, down from $17.8 million in the prior quarter.
• The five-year high for Finished Goods was $19.8 million in Q2 2023, with the low at $7.9 million in Q2 2022.
• Average Finished Goods over 5 years is $14.2 million, with a median of $14.8 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Finished Goods soared 151.65% in 2023, then fell 26.81% in 2025.
• Over 5 years, Finished Goods stood at $12.2 million in 2022, then grew by 29.28% to $15.7 million in 2023, then declined by 10.57% to $14.1 million in 2024, then dropped by 26.81% to $10.3 million in 2025, then increased by 21.32% to $12.5 million in 2026.
• The last three Finished Goods figures came in at $12.5 million (Q2 2026), $17.8 million (Q1 2026), and $10.3 million (Q4 2025), per Business Quant data.